Point72 Hong Kong LTD Syros Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $3,265 - $5,725	-4,732 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $1,046 - $3,898	1,026 Added 27.68%	4,732 $6,000
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $10,940 - $15,638	-3,356 Reduced 47.52%	3,706 $12,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $18,094 - $25,102	4,435 Added 168.82%	7,062 $32,000
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $1,127 - $1,683	225 Added 9.37%	2,627 $14,000
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $5,917 - $12,303	823 Added 52.12%	2,402 $18,000
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $7,599 - $16,727	-1,141 Reduced 41.95%	1,579 $17,000
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $23,636 - $39,358	2,720 New	2,720 $24,000
Q4 2017 Feb 14, 2018	SELL	$8.45 - $17.48 $1,639 - $3,391	-194 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $2,622 - $4,607	194	194 $3,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.